Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,070.00
-100.00 (-1.62%)
At close: Sep 4, 2026

Wonbiogen Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,0708,2607,1963,0363,2267,671
Short-Term Investments
7,0817,1003,6755,5205,3476,087
Cash & Short-Term Investments
11,15115,36010,8708,5568,57313,758
Cash Growth
-11.19%41.30%27.05%-0.19%-37.69%1000.25%
Accounts Receivable
5,5415,3474,8234,9393,1813,545
Other Receivables
201.25161.8281.3279.55164.73293.1
Receivables
5,7425,5084,9055,2413,3463,838
Inventory
6,2945,8985,5247,0645,8494,912
Prepaid Expenses
123.7687.0867.6384.9994.7882.43
Other Current Assets
75.19217.19290.39191.52341.28298.52
Total Current Assets
23,38727,07121,65721,13818,20422,889
Property, Plant & Equipment
24,77317,86316,98217,71117,26811,688
Long-Term Investments
728.141,104905.491,9781,4541,550
Goodwill
151.98151.98313.76510.41510.41510.41
Other Intangible Assets
383.21395.44406.6444.29424.72418.21
Long-Term Deferred Tax Assets
442.81470.11453.48323.54323.2155.28
Other Long-Term Assets
4,015569.07550.57798.14748.16832.77
Total Assets
53,88247,62541,26942,90338,93338,043

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,4161,110837.8696.58721.731,036
Accrued Expenses
691.15565.39456.76385.17364.73304.69
Short-Term Debt
2,500-2006,3608,7007,494
Current Portion of Long-Term Debt
-366.6750-48.2773.2
Current Portion of Leases
216.4250.15163.09268.28198.62195.88
Current Income Taxes Payable
913.52789.9694.06852.76704.542.98
Current Unearned Revenue
54.3857.4440.1237.8814.7661.21
Other Current Liabilities
1,4091,372865.35746.66829.891,731
Total Current Liabilities
7,2004,5113,3079,34711,58310,899
Long-Term Debt
1,500-366.67416.679.9958.26
Long-Term Leases
329.04313.83112.47272.84244.29267.51
Pension & Post-Retirement Benefits
147.84140.61179.54196.26125.84140.03
Other Long-Term Liabilities
3036.2635.9445.63144.34117.49
Total Liabilities
9,2075,0024,00210,27912,10711,482

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3,6963,6963,6963,6963,6453,645
Additional Paid-In Capital
7,5207,5207,5207,5206,92535,611
Retained Earnings
36,60732,93830,03125,04719,909-12,106
Treasury Stock
-2,008-383.05-2,996-2,996-2,996-
Comprehensive Income & Other
-1,045-1,045-1,045-1,045-615.82-447.54
Total Common Equity
44,77142,72637,20732,22226,86726,703
Minority Interest
-95.7-102.5560.65402.62-41.74-141.84
Shareholders' Equity
44,67542,62437,26832,62526,82626,561
Total Liabilities & Equity
53,88247,62541,26942,90338,93338,043

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4,545930.65892.237,3189,2018,089
Net Cash (Debt)
6,60614,4309,9781,238-628.385,669
Net Cash Growth
-43.64%44.61%705.69%---
Net Cash Per Share
946.712034.661406.50162.84-87.33816.08
Filing Date Shares Outstanding
6.817.047.097.096.997.29
Total Common Shares Outstanding
6.817.047.097.096.997.29
Working Capital
16,18722,56018,35011,7906,62111,990
Book Value Per Share
6578.126072.265244.414541.803841.643662.55
Tangible Book Value
44,23542,17936,48731,26725,93225,775
Tangible Book Value Per Share
6499.485994.465142.884407.233707.933535.18
Land
7,5535,6585,6225,5505,3403,582
Buildings
7,5727,4587,3897,2486,9423,417
Machinery
3,3908,8159,0838,6737,6866,510
Construction In Progress
4,8341,1553096.2322.751,083